Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model.
[en] Several biological characteristics of bovine herpesvirus 4 (BoHV-4) make it a good candidate as a gene delivery vector for vaccination purposes. These characteristics include little or no pathogenicity, unlikely oncogenicity, the capability to accommodate large amounts of foreign genetic material, the ability to infect several cell types coming from different animal species, and the ability to maintain transgene expression in both undifferentiated and differentiated cells. Starting from BoHV-4 cloned as a bacterial artificial chromosome (BAC), we used MuA transposase-mediated in vitro transposition to generate recombinant BoHV-4 expressing the immunodominant glycoprotein D (gD) of BoHV-1, one of the most important pathogens of cattle. Although a cis-acting element from woodchuck hepatitis virus (the woodchuck hepatitis virus posttranscriptional regulatory element [WPRE]) in the 3' end of the gD expression cassette was required for maximal gD expression from plasmids in transient transfection assays, this element was not necessary for efficient expression of gD from recombinant BoHV-4 genomes. BoHV-4 recombinants containing gD expression cassettes with or without the WPRE expressed gD at similarly high levels. Several cell lines originating from different animal species expressed gD when infected with BoHV-4 recombinants. When rabbits were immunized with one of the recombinants, high levels of serum neutralizing antibodies against BoHV-1 were generated. This work is one of the first demonstrations of the use BoHV-4 as a vector for vaccine purposes and may provide the basis for BoHV-1 vaccination of cattle with recombinant BoHV-4.
Gillet, Laurent ; Université de Liège - ULiège > Immunologie et vaccinologie
Flammini, Cesidio Filippo
Language :
English
Title :
Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model.
Publication date :
2006
Journal title :
Clinical and Vaccine Immunology
ISSN :
1556-6811
eISSN :
1556-679X
Publisher :
American Society for Microbiology (ASM), Washington, United States - District of Columbia
Ballestas, M. E., P. A. Chatis, and K. M. Kaye. 1999. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641-644.
Bartha, A., M. Juhasz, and H. Liebermann. 1966. Isolation of a bovine herpesvirus from calves with respiratory disease and keratoconjuntivitis. Acta Vet. Acad. Sci. Hung. 16:357-358.
Bublot, M., P. Lomonte, A. S. Lequarre, J. C. Albrecht, J. Nicholas, B. Fleckenstein, P. P. Pastoret, and E. Thiry. 1992. Genetic relationships between bovine herpesvirus 4 and the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. Virology 190:654-655.
Ceserman, E., P. S. Moore, P. H. Rao, G. Inghirami, D. M. Knowles, and Y. Chang. 1995. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86:2708-2714.
Decker, L. L., P. Shankar, G. Khan, R. B. Freeman, B. J. Dezube, J. Lieberman, and D. A. Thorley-Lawson. 1996. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J. Exp. Med. 184:283-288.
Donello, J. E., J. E. Loeb, and T. J. Hope. 1998. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J. Virol. 72: 5085-5092.
Donofrio, G., A. Cavaggioni, M. Bondi, S. Cavirani, C. F. Flammini, and C. Mucignat-Caretta. 2006. Outcome of bovine herpesvirus 4 infection following direct viral injection in the lateral ventricle of the mouse brain. Microb. Infect. 8:898-904.
Donofrio, G., S. Cavirani, and V. L. van Santen. 2000. Establishment of a cell line persistently infected with bovine herpesvirus 4 using a recombinant virus. J. Gen. Virol. 81:1807-1814.
Donofrio, G., S. Cavirani, S. Taddei, and V. L. van Santen. 2002. Potential of bovine herpesvirus 4 as a gene delivery vector. J. Virol. Methods 101:49-61.
Dubuisson, J., E. Thiry, M. Bublot, I. Thomas, M. F. van Bressem, F. Coignoul, and P. P. Pastoret. 1989. Experimental infection of bulls with a genital isolate of bovine herpesvirus-4 and reactivation of latent virus with dexamethasone. Vet. Microbiol. 21:97-114.
Dubuisson, J., E. Thiry, F. Thalasso, M. Bublot, and P. P. Pastoret. 1988. Biological and biochemical comparison of bovid herpesvirus-4 strains. Vet. Microbiol. 16:339-349.
Egyed, L., and A. Bartha. 1998. PCR studies on the potential sites for latency of BHV-4 in calves. Vet. Res. Commun. 22:209-216.
Ehlers, B., H. J. Buhk, and H. Ludwig. 1985. Analysis of bovine cytomegalovirus genome structure: cloning and mapping of the monomeric polyrepetitive DNA unit, and comparison of European and American strains. J. Gen. Virol. 66:55-68.
Gillet, L., V. Daix, G. Donofrio, M. Wagner, U. H. Koszinowski, B. China, M. Ackermann, N. Markine-Goriaynoff, and A. Vanderplasschen. 2005. Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning. J. Gen. Virol. 86:907-917.
Gillet, L., B. Dewals, F. Farnir, L. de Leval, and A. Vanderplasschen. 2005. Bovine herpesvirus 4 induces apoptosis of human carcinoma cell lines in vitro and in vivo. Cancer Res. 15:9463-9472.
Glorioso, J. C., N. A. De Luca, and D. J. Fink. 1995. Development and application of herpes simplex virus vectors for human gene therapy. Annu. Rev. Microbiol. 49:675-710.
Haapa, S., S. Taira, E. Heikkinen, and H. Savilahti. 1999. An efficient and accurate integration of mini-Mu transposons in vitro: a general methodology for functional genetic analysis and molecular biology applications. Nucleic Acids Res. 27:2777-2784.
Jung, J. U., J. K. Choi, A. Ensser, and B. Biesinger. 1999. Herpesvirus saimiri as a model for gammaherpesvirus oncogenesis. Semin. Cancer Biol. 9:231-239.
Kaashoek, M. J., A. Moerman, J. Madic, F. A. Rijsewijk, J. Quak, A. L. Gielkens, and J. T. van Oirschot. 1994. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12:439-444.
Kelleher, Z. T., H. Fu, E. Livanos, B. Wendelburg, S. Gulino, and J. Vos. 1998. Epstein-Barr-based episomal chromosomes shuttle 100 kb of self-replicating circular human DNA in mouse cells. Nat. Biotechnol. 16:762-768.
Kieff, E. 1996. Epstein-Barr virus and its replication, p. 1109-1162. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
Krogman, L. A., and J. P. McAdaragh. 1982. Recrudescence of bovine herpesvirus-5 in experimentally infected calves. Am. J. Vet. Res. 43:336-338.
Kung, S. H., and P. G. Medveczky. 1996. Identification of a herpesvirus saimiri cis-acting DNA fragment that permits stable replication of episomes in transformed T cells. J. Virol. 70:1738-1744.
Lomonte, P., M. Bublot, V. L. vanSanten, G. Keil, P. P. Pastoret, and E. Thiry. 1996. Bovine herpesvirus 4: genomic organization and relationship with two other gammaherpesviruses, Epstein-Barr virus and herpesvirus saimiri. Vet. Microbiol. 53:79-89.
Ludwig, H. 1983. Bovine herpesviruses, p. 135-214. In B. Roizman (ed.), The herpesviruses, vol. 2. Plenum Press, New York, N.Y.
Mohanty, S. B., R. C. Hammond, and M. G. Lillie. 1971. A new bovine herpesvirus and its effect on experimentally infected calves. Arch. Gesamte Virusforsch. 34:394-395.
Moses, A. V., K. N. Fish, R. Ruhl, P. P. Smith, J. G. Strussenberg, L. Zhu, B. Chandran, and J. A. Nelson. 1999. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J. Virol. 73:6892-6902.
Naeem, K., D. D. Caywood, S. M. Goyal, R. E. Werdin, and M. P. Murtaugh. 1993. Persistence of bovid herpesvirus-4 in experimentally inoculated pregnant rabbits. New Microbiol. 16:87-93.
Osorio, F. A., and D. E. Reed. 1983. Experimental inoculation of cattle with bovine herpesvirus-4: evidence for a lymphoid-associated persistent infection. Am. J. Vet. Res. 44:975-980.
Osorio, F. A., D. E. Reed, and D. L. Rock. 1982. Experimental infection of rabbits with bovine herpesvirus-4: acute and persistent infection. Vet. Microbiol. 7:503-513.
Osorio, F. A., D. L. Rock, and D. E. Reed. 1985. Studies on the pathogenesis of a bovine cytomegalo-like virus in an experimental host. J. Gen. Virol. 66:1941-1951.
Peterson, R. B., and S. M. Goyal. 1988. Propagation and quantitation of animal herpesviruses in eight cell culture systems. Comp. Immunol. Microbiol. Infect. Dis. 11:93-98.
Savilahti, H., P. A. Rice, and K. Mizuuchi. 1995. The phage Mu transpososome core: DNA requirements for assembly and function. EMBO J. 14: 4893-4903.
Storz, J., B. Ehlers, V. J. Todd, and H. Ludwig. 1984. Bovine cytomegaloviruses: identification and differential properties. J. Gen. Virol. 65:697-706.
Thiry, E., M. Bublot, J. Dubuisson, and P. P. Pastoret. 1989. Bovine herpesvirus-4 (BHV-4) infection in cattle, p. 96-115. In G. Wittmann (ed.), Herpesvirus diseases of cattle, horses and pigs. Kluwer, Boston, Mass.
Usherwood, E. J., J. P. Stewart, and A. A. Nash. 1996. Characterization of tumor cell lines derived from murine gammaherpesvirus-68- infected mice. J. Virol. 70:6516-6518.
Vanderplasschen, A., M. Goltz, J. Lyaku, C. Benarafa, H. J. Buhk, E. Thiry, and P. P. Pastoret. 1995. The replication in vitro of the gammaherpesvirus bovine herpesvirus 4 is restricted by its DNA synthesis dependence on the S phase of the cell cycle. Virology 10:328-340.
van Drunen Littel-van den Hurk, S., S. L. Babiuk, and L. A. Babiuk. 2004. Strategies for improved formulation and delivery of DNA vaccines to veterinary target species. Immunol. Rev. 199:113-125.
Wyler, R., M. Engels, and M. Schwyzer. 1989. Infectious bovine rhinotracheitis/vulvo-vaginitis (BHV-1), p. 1-72. In G. Wittmann (ed.), Herpesvirus diseases of cattle, horses and pigs. Kluwer, Boston, Mass.
Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806-3810.
Zimmermann, W., H. Broll, B. Ehlers, H. J. Buhk, A. Rosenthal, and M. Goltz. 2001. Genome sequence of bovine herpesvirus 4, a bovine Rhadinovirus, and identification of an origin of DNA replication. J. Virol. 75:1186-1194.
Zufferey, R., J. E. Donello, D. Trono, and T. J. Hope. 1999. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73:2886-2892.
